PAG
ABEO icon

Private Advisor Group’s Abeona Therapeutics ABEO Stock Holding History

Private Advisor Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-46
Closed -$3K – 1561
2020
Q2 		$3K Buy
+46
New +$3.18K ﹤0.01% 3403
2017
Q3 		– Sell
-409
Closed -$94K – 1464
2017
Q2 		$94K Sell
409
-431
-51% -$58.8K ﹤0.01% 1334
2017
Q1 		$108K Buy
840
+280
+50% +$36.1K ﹤0.01% 1354
2016
Q4 		$75K Buy
+560
New +$87.7K ﹤0.01% 1227

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Advisor Group's ABEO Position: Q3 2020 in Review

Private Advisor Group sold out of Abeona Therapeutics (ABEO) in Q3 2020, closing a stake of 46 shares — an estimated $3K sold.

Private Advisor Group first reported a position in ABEO in Q4 2016 and held it in 4 quarters. The position peaked at $108K in Q1 2017. 78 funds tracked by Wall St. Rank hold ABEO as of Q3 2020.

  • Private Advisor Group reported no remaining Abeona Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 46 Abeona Therapeutics shares in Q3 2020, an estimated $3K.
  • Private Advisor Group first reported a position in Abeona Therapeutics in Q4 2016 and held it in 4 quarters.
  • Private Advisor Group's Abeona Therapeutics position peaked at $108K in Q1 2017.
  • 78 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.